{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:51:41Z","timestamp":1791636701046,"version":"4.3.4"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81770736"],"award-info":[{"award-number":["No. 81770736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Cardiovascular Association\u2013Natural Lipid-Lowering Drugs Fund","award":["No. 2023-CCA-NLD-742"],"award-info":[{"award-number":["No. 2023-CCA-NLD-742"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The concept of anticoagulant-related nephropathy (ARN), first proposed in 2009, manifests as acute kidney injury or the rapid deterioration of chronic kidney disease secondary to anticoagulant therapy. Large numbers of tubular RBCs and\/or tubular RBC casts and ATN, without active glomerulonephritis are the main pathological features. The history of anticoagulant drug use and pathological manifestations are the most important characteristics that distinguish it from other renal injuries. ARN is considered rare, with just over 100 cases documented globally, yet its incidence may be underestimated due to limited awareness.<\/jats:p>\n                  <jats:p>This article reviews the epidemiology, risk factors, etiology and pathogenesis, diagnosis and treatment of ARN. New advances in recent years are highlighted, including the relationship between ARN and other kidney diseases, the characteristics of nonvitamin K oral anticoagulants and their effects on renal function, and the complexities of peri-biopsy and therapeutic anticoagulation.<\/jats:p>\n                  <jats:p>To address the critical peri-biopsy management impasse, we evaluated anticoagulation strategies from published case reports. Integrating these empirical insights with established perioperative antithrombotic principles, we propose a synthesized strategy for ARN management during the peri-biopsy and treatment phases, accompanied by a diagnostic flowchart. Given the current reliance on case-level evidence, this review does not intend to issue definitive clinical guidelines. Rather, it aims to build a comprehensive cognitive framework and a structured consideration system, facilitating nuanced assessments to ultimately improve patient outcomes in this challenging clinical domain.<\/jats:p>","DOI":"10.1093\/ckj\/sfag325","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:45:11Z","timestamp":1789213511000},"source":"Crossref","is-referenced-by-count":0,"title":["Recent advances in anticoagulant-related nephropathy: risk factors, peribiopsy, and therapeutic anticoagulation"],"prefix":"10.1093","volume":"19","author":[{"given":"Yiwen","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hubei Cancer Hospital , Wuhan, Hubei ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JingJing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]},{"name":"Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-8024","authenticated-orcid":false,"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0476-3198","authenticated-orcid":false,"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"2026101007565852100_bib1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int"},{"key":"2026101007565852100_bib2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40119-013-0016-1","article-title":"Dabigatran excess: case report and review of the literature","volume":"2","author":"Sarma","year":"2013","journal-title":"Cardiol Thery"},{"key":"2026101007565852100_bib3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/298261","article-title":"Dabigatran-related nephropathy in a patient with undiagnosed IgA nephropathy","volume":"2015","author":"Escoli","year":"2015","journal-title":"Case Rep Nephrol"},{"key":"2026101007565852100_bib4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/jcm10040796","article-title":"Management of anticoagulant-related nephropathy: a single center experience","volume":"10","author":"Tanja","year":"2021","journal-title":"J Clin Med"},{"key":"2026101007565852100_bib5","first-page":"221","article-title":"Anticoagulation-related nephropathy: an uncommon enemy!","volume":"33","author":"Sengupta","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2026101007565852100_bib6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/0886022X.2021.2014338","article-title":"Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use","volume":"44","author":"Deng","year":"2022","journal-title":"Ren Fail"},{"key":"2026101007565852100_bib7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","article-title":"Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases","volume":"54","author":"Brodsky","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026101007565852100_bib8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.xkme.2019.03.002","article-title":"Nadasdy T: anticoagulant-related nephropathy in kidney biopsy: a single-center report of 41 cases","volume":"1","author":"Brodsky","year":"2019","journal-title":"Kidney Med"},{"key":"2026101007565852100_bib9","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1681\/ASN.2018070741","article-title":"Anticoagulant-related nephropathy","volume":"29","author":"Brodsky","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2026101007565852100_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ckj\/sfy133","article-title":"Anticoagulant-related nephropathy: systematic review and meta-analysis","volume":"12","author":"de\u00a0Aquino\u00a0Moura","year":"2019","journal-title":"Clin Kidney J"},{"key":"2026101007565852100_bib11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ckj\/sft076","article-title":"Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin","volume":"6","author":"Moeckel","year":"2013","journal-title":"Clin Kidney J"},{"key":"2026101007565852100_bib12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.mcna.2020.02.005","article-title":"Periprocedural management of oral anticoagulation","volume":"104","author":"Shaw","year":"2020","journal-title":"Med Clin North Am"},{"key":"2026101007565852100_bib13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.kint.2019.11.027","article-title":"Role of direct oral anticoagulants in patients with kidney disease","volume":"97","author":"Derebail","year":"2020","journal-title":"Kidney Int"},{"key":"2026101007565852100_bib14","first-page":"776","article-title":"Oral anticoagulation","volume":"115","author":"Altiok","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"2026101007565852100_bib15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"2026101007565852100_bib16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026101007565852100_bib17","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"key":"2026101007565852100_bib18","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Investigators","year":"2010","journal-title":"N Engl J Med"},{"key":"2026101007565852100_bib19","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"2026101007565852100_bib20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"2026101007565852100_bib21","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.4103\/jfmpc.jfmpc_671_19","article-title":"Warfarin: a double-edged sword","volume":"8","author":"Yadav","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"2026101007565852100_bib22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11239-018-1626-1","article-title":"Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study","volume":"45","author":"Piran","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"2026101007565852100_bib23","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1681\/ASN.0000000000000199","article-title":"The crosstalk between nephropathy and coagulation disorder: pathogenesis, treatment, and dilemmas","volume":"34","author":"Qiu","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026101007565852100_bib24","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.ekir.2020.08.005","article-title":"Anticoagulant-related nephropathy in a renal transplant recipient","volume":"5","author":"Tennekoon","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026101007565852100_bib25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ekir.2022.01.1048","article-title":"IgA nephropathy is the most common underlying disease in patients with anticoagulant-related nephropathy IgA","volume":"7","author":"Trujillo","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2026101007565852100_bib26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2022.12.002","article-title":"Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: clinical characteristics, treatments and outcomes","volume":"222","author":"Chen","year":"2023","journal-title":"Thromb Res"},{"key":"2026101007565852100_bib27","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"2026101007565852100_bib28","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2215\/CJN.13251118","article-title":"Spanish group for the study of glomerular D: IgA nephropathy in elderly patients","volume":"14","author":"Sevillano","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101007565852100_bib29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","article-title":"IgA nephropathy: core curriculum 2021","volume":"78","author":"Pattrapornpisut","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2026101007565852100_bib30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.kint.2023.04.029","article-title":"IgA nephropathy: the lectin pathway and implications for targeted therapy","volume":"104","author":"Barratt","year":"2023","journal-title":"Kidney Int"},{"key":"2026101007565852100_bib31","doi-asserted-by":"publisher","first-page":"c142","DOI":"10.1159\/000312877","article-title":"Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease","volume":"115","author":"Brodsky","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"2026101007565852100_bib32","doi-asserted-by":"publisher","first-page":"e57661","DOI":"10.1371\/journal.pone.0057661","article-title":"The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in Korean patients","volume":"8","author":"An","year":"2013","journal-title":"PLoS One"},{"key":"2026101007565852100_bib33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11255-012-0364-0","article-title":"Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation","volume":"45","author":"Lim","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"2026101007565852100_bib34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000337918","article-title":"5\/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy","volume":"35","author":"Ozcan","year":"2012","journal-title":"Am J Nephroly"},{"key":"2026101007565852100_bib35","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/ndt\/gft380","article-title":"Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats","volume":"29","author":"Ryan","year":"2014","journal-title":"Nephrol Dialysis Transpl"},{"key":"2026101007565852100_bib36","doi-asserted-by":"publisher","first-page":"F1421","DOI":"10.1152\/ajprenal.00689.2012","article-title":"N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy","volume":"304","author":"Ware","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026101007565852100_bib37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1681\/ASN.2006080894","article-title":"Physiology and pathophysiology of heme: implications for kidney disease","volume":"18","author":"Tracz","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026101007565852100_bib38","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/cells8111389","article-title":"The role of inflammasome-dependent and inflammasome-independent NLRP3 in the kidney","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"key":"2026101007565852100_bib39","first-page":"425","article-title":"Developing PAR1 antagonists: minding the endothelial gap","volume":"13","author":"Ramachandran","year":"2012","journal-title":"Discov Med"},{"key":"2026101007565852100_bib40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jth.13229","article-title":"Anticoagulation-related nephropathy","volume":"14","author":"Wheeler","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2026101007565852100_bib41","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2215\/CJN.00770208","article-title":"Vitamin K-dependent proteins, warfarin, and vascular calcification","volume":"3","author":"Danziger","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101007565852100_bib42","first-page":"934","article-title":"Analysis of one case of warfarin related nephropathy","volume":"17","author":"Hehe","year":"2020","journal-title":"Chin J Pharmacovigilance"},{"key":"2026101007565852100_bib43","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians Clinical Practice Guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"2026101007565852100_bib44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40620-023-01781-y","article-title":"Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban","volume":"37","author":"Vischini","year":"2024","journal-title":"J Nephroly"},{"key":"2026101007565852100_bib45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5414\/CN111156","article-title":"Pitfalls in anticoagulant-related nephropathy","volume":"100","author":"Kock","year":"2023","journal-title":"Clin Nephrol"},{"key":"2026101007565852100_bib46","first-page":"e22038","article-title":"Anticoagulant-related nephropathy: a common, under-diagnosed clinical entity","volume":"14","author":"Afiari","year":"2022","journal-title":"Cureus"},{"key":"2026101007565852100_bib47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8952670","article-title":"Acute kidney injury due to anticoagulant-related nephropathy:\u2009a suggestion for therapy","volume":"2020","author":"Zeni","year":"2020","journal-title":"Case Rep Nephrol"},{"key":"2026101007565852100_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1874303X01912010041","article-title":"Pigment nephropathy and warfarin-related nephropathy as aetiology for acute kidney injury in a patient with mechanical heart valves","volume":"12","author":"Whammy","year":"2019","journal-title":"Open Urol Nephrol J"},{"key":"2026101007565852100_bib49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12882-016-0228-4","article-title":"Warfarin related nephropathy: a case report and review of the literature","volume":"17","author":"Ng","year":"2016","journal-title":"BMC Nephrol"},{"key":"2026101007565852100_bib50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2024.12708","article-title":"Perioperative management of patients taking direct oral anticoagulants: a review","volume":"332","author":"Douketis","year":"2024","journal-title":"JAMA"},{"key":"2026101007565852100_bib51","first-page":"3058","article-title":"\u4e2d\u56fd\u5fc3\u8840\u7ba1\u5065\u5eb7\u8054\u76df: \u6297\u8840\u6813\u836f\u7269\u56f4\u624b\u672f\u671f\u7ba1\u7406\u591a\u5b66\u79d1\u4e13\u5bb6\u5171\u8bc6","volume":"100","author":"\u4e2d\u56fd\u5fc3\u80f8\u8840\u7ba1\u9ebb\u9189\u5b66\u4f1a\u975e\u5fc3\u810f\u9ebb\u9189\u5206\u4f1a","year":"2020","journal-title":"\u4e2d\u534e\u533b\u5b66\u6742\u5fd7"},{"key":"2026101007565852100_bib52","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates","volume":"126","author":"Siegal","year":"2012","journal-title":"Circulation"},{"key":"2026101007565852100_bib53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000550757","article-title":"Beyond oral anticoagulants two case reports of biopsy-proven heparin-induced anticoagulant-related nephropathy","volume":"150","author":"Islami","year":"2026","journal-title":"Nephron"},{"key":"2026101007565852100_bib54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11239-007-0022-z","article-title":"Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin","volume":"24","author":"Woods","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"2026101007565852100_bib55","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.kint.2025.04.003","article-title":"Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)","volume":"108","author":"Floege","year":"2025","journal-title":"Kidney Int"},{"key":"2026101007565852100_bib56","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s40620-022-01413-x","article-title":"A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease","volume":"35","author":"Parker","year":"2022","journal-title":"J Nephrol"},{"key":"2026101007565852100_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"Group ESD: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2026101007565852100_bib58","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","article-title":"Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"39","author":"Turakhia","year":"2018","journal-title":"Eur Heart J"},{"key":"2026101007565852100_bib59","first-page":"164","article-title":"Association TvsgotacsboCM: Chinese expert consensus on anticoagulation in heart valve surgery","volume":"38","author":"The Group of Valve Surgery, Chinese Society of Thoracic and Cardiovascular Surgery, Chinese Medical Association","year":"2022","journal-title":"Chin J Thorac Cardiovasc Surg"},{"key":"2026101007565852100_bib60","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.4244\/EIJ-D-22-00627","article-title":"Left atrial appendage occlusion","volume":"18","author":"Holmes","year":"2023","journal-title":"EuroIntervention"},{"key":"2026101007565852100_bib61","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1024\/0301-1526\/a000887","article-title":"Inferior vena cava filter\u2014comprehensive overview of current indications, techniques, complications and retrieval rates","volume":"49","author":"Li","year":"2020","journal-title":"Vasa"},{"key":"2026101007565852100_bib62","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ekir.2023.04.014","article-title":"Clinical outcomes in patients with biopsy proven anticoagulant-related nephropathy","volume":"8","author":"Dasgupta","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026101007565852100_bib63","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-pharmtox-032823-122811","article-title":"Ten Cate H: oral Anticoagulants Beyond Warfarin","volume":"64","author":"Olie","year":"2024","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag325\/71048086\/sfag325.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag325\/71048086\/sfag325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag325\/71048086\/sfag325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:57:05Z","timestamp":1791633425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag325\/8793097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag325","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,12]]},"article-number":"sfag325"}}